Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury

Traumatic brain injury (TBI) in various forms affects millions in the United States annually. There are currently no FDA-approved therapies for acute injury or the chronic comorbidities associated with TBI. Acute phases of TBI are characterized by profound neuroinflammation, a process that stimulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Thome, Jason G., Reeder, Evan L., Collins, Sean M., Gopalan, Poornima, Robson, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985078/
https://www.ncbi.nlm.nih.gov/pubmed/32038189
http://dx.doi.org/10.3389/fnbeh.2019.00287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985078/
https://www.ncbi.nlm.nih.gov/pubmed/32038189
http://dx.doi.org/10.3389/fnbeh.2019.00287

Ejemplares similares